Research
Periodic Report
Glenmark Soars on AbbVie Deal, Anand Rathi Beats Q1 Estimates, RITES Bags ₹46.8 Cr Govt Order
Glenmark Soars on AbbVie Deal, Anand Rathi Beats Q1 Estimates, RITES Bags ₹46.8 Cr Govt Order
Written by - Fisdom Research
Array
July 11, 2025
2 minutes
Array
Market Snapshot
Benchmark indices extended losses for the third straight session on July 11, with the Nifty 50 slipping below the 25,200 mark.
Sentiment was weighed down by concerns over proposed Trump-era tariffs and post-earnings pressure in IT stocks, especially after TCS’s Q1 FY26 results.
Former President Trump announced a 35% tariff on Canadian imports and signaled broader tariffs of 15–20% on other trading partners, spooking global markets.
Sectoral performance was broadly negative, with FMCG (+0.5%) and Pharma (+0.7%) as the only gainers.
Auto, IT, media, oil & gas, consumer durables, capital goods, realty, and telecom sectors each declined around 1%.
Sectoral Trends
Sector Name
% Change
Sector Name
% Change
NIFTY PHARMA
0.7
NIFTY PSU BANK
-0.1
NIFTY FMCG
0.5
NIFTY METAL
-0.4
NIFTY HEALTHCARE INDEX
0.1
NIFTY CONSUMER DURABLES
-1.0
NIFTY PRIVATE BANK
-0.1
NIFTY REALTY
-1.2
Top News
Glenmark Pharma surged 15% to a 52-week high after its subsidiary signed an exclusive global licensing deal with AbbVie for cancer drug candidate ISB 2001, currently in Phase 1 trials.
Anand Rathi Wealth gained over 5% following strong Q1FY26 results, with net profit up 27.9% YoY and EBITDA margin improving to 46.6%.
RITES secured a ₹46.82 crore turnkey order from the Karnataka government for construction and renovation of government colleges, marking a shift from PMC to full project execution.
Top Gainers and Losers
Top Gainers
% Change
Top Losers
% Change
HINDUNILVR
4.6
TCS
-3.5
SBILIFE
1.4
M&M
-2.9
SUNPHARMA
0.7
HEROMOTOCO
-2.7
Trade Ideas Update
Our trade ideas success rate has 83% over the past month, even with increased volatility in the benchmark index. Follow Trade Ideas for timely stock insights.
